Literature DB >> 23567639

Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis.

Joshua Lopes1, Eser Adiguzel, Steven Gu, Shu-Lin Liu, Guangpei Hou, Scott Heximer, Richard K Assoian, Michelle P Bendeck.   

Abstract

Collagens in the atherosclerotic plaque signal regulation of cell behavior and provide tensile strength to the fibrous cap. Type VIII collagen, a short-chain collagen, is up-regulated in atherosclerosis; however, little is known about its functions in vivo. We studied the response to arterial injury and the development of atherosclerosis in type VIII collagen knockout mice (Col8(-/-) mice). After wire injury of the femoral artery, Col8(-/-) mice had decreased vessel wall thickening and outward remodeling when compared with Col8(+/+) mice. We discovered that apolipoprotein E (ApoE) is an endogenous repressor of the Col8a1 chain, and, therefore, in ApoE knockout mice, type VIII collagen was up-regulated. Deficiency of type VIII collagen in ApoE(-/-) mice (Col8(-/-);ApoE(-/-)) resulted in development of plaques with thin fibrous caps because of decreased smooth muscle cell migration and proliferation and reduced accumulation of fibrillar type I collagen. In contrast, macrophage accumulation was not affected, and the plaques had large lipid-rich necrotic cores. We conclude that in atherosclerosis, type VIII collagen is up-regulated in the absence of ApoE and functions to increase smooth muscle cell proliferation and migration. This is an important mechanism for formation of a thick fibrous cap to protect the atherosclerotic plaque from rupture.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23567639      PMCID: PMC3668035          DOI: 10.1016/j.ajpath.2013.02.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury.

Authors:  G Hou; D Mulholland; M A Gronska; M P Bendeck
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis.

Authors:  S Sinha; C M Kielty; A M Heagerty; A E Canfield; C A Shuttleworth
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

Review 3.  Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis.

Authors:  Gabriele A M Plenz; Mario C Deng; Horst Robenek; Wolfgang Völker
Journal:  Atherosclerosis       Date:  2003-01       Impact factor: 5.162

4.  Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.

Authors:  B Zhu; D G Kuhel; D P Witte; D Y Hui
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  Differential expression of the alpha1 type VIII collagen gene by smooth muscle cells from atherosclerotic plaques of apolipoprotein-E-deficient mice.

Authors:  O Yasuda; S H Zhang; Y Miyamoto; N Maeda
Journal:  J Vasc Res       Date:  2000 May-Jun       Impact factor: 1.934

6.  A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia.

Authors:  M Sata; Y Maejima; F Adachi; K Fukino; A Saiura; S Sugiura; T Aoyagi; Y Imai; H Kurihara; K Kimura; M Omata; M Makuuchi; Y Hirata; R Nagai
Journal:  J Mol Cell Cardiol       Date:  2000-11       Impact factor: 5.000

7.  Cell surface-bound collagenase-1 and focal substrate degradation stimulate the rear release of motile vascular smooth muscle cells.

Authors:  S Li; L H Chow; J G Pickering
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

8.  Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization.

Authors:  Chad Johnson; Zorina S Galis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

9.  Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia.

Authors:  Masafumi Kuzuya; Shigeru Kanda; Takeshi Sasaki; Norika Tamaya-Mori; Xian Wu Cheng; Takeshi Itoh; Shigeyoshi Itohara; Akihisa Iguchi
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

10.  Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.

Authors:  Devashish Kothapalli; Ilia Fuki; Kamilah Ali; Sheryl A Stewart; Liang Zhao; Ron Yahil; David Kwiatkowski; Elizabeth A Hawthorne; Garret A FitzGerald; Michael C Phillips; Sissel Lund-Katz; Ellen Puré; Daniel J Rader; Richard K Assoian
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more
  22 in total

1.  Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer.

Authors:  Nicholas Willumsen; Lars Nannestad Jorgensen; Morten Asser Karsdal
Journal:  Cancer Biol Ther       Date:  2019-01-09       Impact factor: 4.742

2.  Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice.

Authors:  Jungsil Kim; Jesse D Procknow; Hiromi Yanagisawa; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

Review 3.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

4.  Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.

Authors:  Brittany G Durgin; Olga A Cherepanova; Delphine Gomez; Themistoclis Karaoli; Gabriel F Alencar; Joshua T Butcher; Yu-Qing Zhou; Michelle P Bendeck; Brant E Isakson; Gary K Owens; Jessica J Connelly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-10       Impact factor: 4.733

Review 5.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

6.  CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis.

Authors:  Yvonne Baumer; Sara McCurdy; Martin Alcala; Nehal Mehta; Bog-Hieu Lee; Mark H Ginsberg; William A Boisvert
Journal:  Atherosclerosis       Date:  2016-11-16       Impact factor: 5.162

7.  Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis.

Authors:  Zan Shen; Chen Yao; Zifeng Wang; Lu Yue; Zheping Fang; Hong Yao; Feng Lin; Hui Zhao; Yuan-Jue Sun; Xiu-Wu Bian; Wenqi Jiang; Xiaomei Wang; Yi Li; Gang Lu; Wai Sang Poon; Hsiang-Fu Kung; Marie Chia-Mi Lin
Journal:  Mol Ther       Date:  2016-03-10       Impact factor: 11.454

8.  Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy.

Authors:  J Spencer Hauck; Jeovanna Lowe; Neha Rastogi; Kevin E McElhanon; Jennifer M Petrosino; Kyra K Peczkowski; Ashlee N Chadwick; Jonathan G Zins; Federica Accornero; Paul M L Janssen; Noah L Weisleder; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

9.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

Review 10.  Role of smooth muscle cells in coronary artery bypass grafting failure.

Authors:  Kerry Wadey; Joshua Lopes; Michelle Bendeck; Sarah George
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.